Literature DB >> 3875856

The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors.

L C Pan, P A Price.   

Abstract

The molecular cloning of bone gamma-carboxyglutamic acid (Gla) protein (BGP; osteocalcin) was accomplished by constructing a phage lambda gt11 cDNA library from the rat osteosarcoma cell line ROS 17/2 and screening this library with antibodies raised against BGP from rat bone. By sequencing several cloned cDNAs, we have established a 489-base-pair sequence that predicts a mature BGP of 50 amino acid residues with an NH2-terminal extension of 49 residues. The leader peptide consists of a hydrophobic signal peptide followed by a basic propeptide of 26 or 27 residues that is cleaved after an Arg-Arg dipeptide prior to secretion from the cell. Mature rat BGP is extremely homologous to BGPs from other species except for its COOH-terminal sequence. A stretch of 9 residues proximal to the NH2 terminus of secreted BGP is strikingly similar to the corresponding regions in known propeptides of the gamma-carboxyglutamic acid-containing blood coagulation factors. We suggest that this common structural feature may be involved in the posttranslational targeting of these polypeptides for vitamin K-dependent gamma-carboxylation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875856      PMCID: PMC390709          DOI: 10.1073/pnas.82.18.6109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Pre-proparathyroid hormone; amino acid sequence, chemical synthesis, and some biological studies of the precursor region.

Authors:  J F Habener; M Rosenblatt; B Kemper; H M Kronenberg; A Rich; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli.

Authors:  J Brosius; M L Palmer; P J Kennedy; H F Noller
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

5.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

6.  Further procedures for sequence analysis by computer.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1978-03       Impact factor: 16.971

7.  Vitamin K-dependent carboxylase: requirements for carboxylation of soluble peptide and substrate specificity.

Authors:  J W Suttie; S R Lehrman; L O Geweke; J M Hageman; D H Rich
Journal:  Biochem Biophys Res Commun       Date:  1979-02-14       Impact factor: 3.575

8.  Sequence data handling by computer.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1977-11       Impact factor: 16.971

9.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

10.  The vitamin K-dependent bone protein is accumulated within cultured osteosarcoma cells in the presence of the vitamin K antagonist warfarin.

Authors:  S K Nishimoto; P A Price
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

View more
  33 in total

1.  Identification and purification to near homogeneity of the vitamin K-dependent carboxylase.

Authors:  S M Wu; D P Morris; D W Stafford
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells.

Authors:  J D Fraser; P A Price
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

Review 3.  Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

4.  Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation.

Authors:  P J O'Hara; F J Grant; B A Haldeman; C L Gray; M Y Insley; F S Hagen; M J Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa.

Authors:  Veena S Rao; Jeremiah S Joseph; R Manjunatha Kini
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

6.  The cDNA and derived amino acid sequences of human and bovine bone Gla protein.

Authors:  M C Kiefer; A C Saphire; D M Bauer; P J Barr
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

7.  Functional Study of the Vitamin K Cycle Enzymes in Live Cells.

Authors:  J-K Tie; D W Stafford
Journal:  Methods Enzymol       Date:  2016-11-22       Impact factor: 1.600

8.  Vitamin K-dependent carboxylase: possible role of the substrate "propeptide" as an intracellular recognition site.

Authors:  J W Suttie; J A Hoskins; J Engelke; A Hopfgartner; H Ehrlich; N U Bang; R M Belagaje; B Schoner; G L Long
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

9.  The propeptide region of clotting factor IX is a signal for a vitamin K dependent carboxylase: evidence from protein engineering of amino acid -4.

Authors:  P Galeffi; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

10.  A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism.

Authors:  K Chu; S M Wu; T Stanley; D W Stafford; K A High
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.